(Updated - May 18, 2022 6:36 AM EDT)

Baird analyst Madhu Kumar upgraded Cellectis (NASDAQ: CLLS) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE